Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.
犹他州盐湖城，2025年1月6日（GLOBE NEWSWIRE）——Recursion（纳斯达克股票代码：RXRX）是一家领先的临床阶段科技生物公司，致力于解码生物学以从根本上改善生活。该公司今天宣布，联合创始人兼首席执行官克里斯·吉布森博士将出席即将在旧金山举行的第43届摩根大通医疗年度会议。
On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion's latest clinical pipeline, partnerships, and platform following the company's recent combination with Exscientia. The talk will be available on Recursion's website for at least 30 days following the presentation here: .
太平洋时间1月13日星期一上午7点30分（美国东部时间上午10点30分），吉布森博士将在圣弗朗西斯威斯汀酒店的伊丽莎白女王会议室A/b室介绍Recursion最近与Exscientia合并后的最新临床管道、合作伙伴关系和平台的最新情况。该讲座将在Recursion的网站上播出至少30天，在此处进行演讲:.
CONTACT: Ryan Kelly
Recursion Pharmaceuticals
media@recursion.com
联系人：瑞安·凯利
递归制药
media@recursion.com
